Skip to Content

Notice

NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2016

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

ACTION:

Notice of issuance of final guidance publication.

SUMMARY:

The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), announces the availability of the following publication: NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2016 [2016-161].

ADDRESSES:

This document may be obtained at the following link: http://www.cdc.gov/​niosh/​docs/​2016-161/​.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Barbara A. MacKenzie, NIOSH Division of Applied Research and Technology, 1090 Tusculum Avenue, MS C-26, Cincinnati, OH 45226. 513-533-8132 (not a toll free number), bmackenzie@cdc.gov.

Start Signature

Dated: September 27, 2016.

Frank Hearl,

Chief of Staff, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.

End Signature End Further Info End Preamble

[FR Doc. 2016-23719 Filed 9-30-16; 8:45 am]

BILLING CODE 4163-19-P